undamentalytics Newsletter

Senestech, Inc. revenue

Senestech, Inc.'s revenue was $2.2m in fiscal 2025, up 19.6% on the year before. Since fiscal 2015 ($241,000) it has grown at a compound 24.9% a year. Over the last twelve months it was $2.4m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Senestech, Inc.: revenue history, annual
Fiscal year2015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue241318522971432826001,0191,1931,8572,2212,374
Growth on the year before—+32.0%−83.6%+471.2%−51.9%+97.2%+112.8%+69.8%+17.1%+55.7%+19.6%—
Gross profit—3187564212444645391,0041,3881,571
Gross margin—100.0%13.5%18.9%29.4%0.4%40.7%45.5%45.2%54.1%62.5%66.2%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Specialty Chemicals: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Senestech, Inc. $2.4m 13.4% 29.8%
Park Ha Biological Technology Co., Ltd. $2.5m 6.0% —
Zone Frontier Inc. $3.4m 64.2% —
Citrotech Inc. $1.3m -26.4% 134.1%
Research Frontiers Inc $654,232 -46.5% -2.9%
J-star Holding Co., Ltd. $9.9m -43.5% —

Compare with peers

Head to head: BYAH vs SNESSNES vs ZONECITR vs SNESREFR vs SNES

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Senestech, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Senestech, Inc.